188 related articles for article (PubMed ID: 30193808)
1. Disrupting interaction of PSD-95 with nNOS attenuates hemorrhage-induced thalamic pain.
Cai W; Wu S; Pan Z; Xiao J; Li F; Cao J; Zang W; Tao YX
Neuropharmacology; 2018 Oct; 141():238-248. PubMed ID: 30193808
[TBL] [Abstract][Full Text] [Related]
2. A pain killer without analgesic tolerance designed by co-targeting PSD-95-nNOS interaction and α2-containning GABA
Li J; Zhang L; Xu C; Shen YY; Lin YH; Zhang Y; Wu HY; Chang L; Zhang YD; Chen R; Zhang ZP; Luo CX; Li F; Zhu DY
Theranostics; 2021; 11(12):5970-5985. PubMed ID: 33897893
[TBL] [Abstract][Full Text] [Related]
3. Dissociation of nNOS from PSD-95 promotes functional recovery after cerebral ischaemia in mice through reducing excessive tonic GABA release from reactive astrocytes.
Lin YH; Liang HY; Xu K; Ni HY; Dong J; Xiao H; Chang L; Wu HY; Li F; Zhu DY; Luo CX
J Pathol; 2018 Feb; 244(2):176-188. PubMed ID: 29053192
[TBL] [Abstract][Full Text] [Related]
4. Small molecule inhibitors of PSD95-nNOS protein-protein interactions as novel analgesics.
Lee WH; Xu Z; Ashpole NM; Hudmon A; Kulkarni PM; Thakur GA; Lai YY; Hohmann AG
Neuropharmacology; 2015 Oct; 97():464-75. PubMed ID: 26071110
[TBL] [Abstract][Full Text] [Related]
5. PSD95 and nNOS interaction as a novel molecular target to modulate conditioned fear: relevance to PTSD.
Li LP; Dustrude ET; Haulcomb MM; Abreu AR; Fitz SD; Johnson PL; Thakur GA; Molosh AI; Lai Y; Shekhar A
Transl Psychiatry; 2018 Aug; 8(1):155. PubMed ID: 30108200
[TBL] [Abstract][Full Text] [Related]
6. FTO (Fat-Mass and Obesity-Associated Protein) Participates in Hemorrhage-Induced Thalamic Pain by Stabilizing Toll-Like Receptor 4 Expression in Thalamic Neurons.
Fu G; Du S; Huang T; Cao M; Feng X; Wu S; Albik S; Bekker A; Tao YX
Stroke; 2021 Jul; 52(7):2393-2403. PubMed ID: 34102854
[TBL] [Abstract][Full Text] [Related]
7. Disrupting nNOS-PSD95 Interaction Improves Neurological and Cognitive Recoveries after Traumatic Brain Injury.
Qu W; Liu NK; Wu X; Wang Y; Xia Y; Sun Y; Lai Y; Li R; Shekhar A; Xu XM
Cereb Cortex; 2020 Jun; 30(7):3859-3871. PubMed ID: 31989159
[TBL] [Abstract][Full Text] [Related]
8. Uncoupling nNOS-PSD-95 in mPFC inhibits morphine priming-induced reinstatement after extinction training.
Kou XL; Tao Y; Xian JY; Lin YH; Cai CY; Wu HY; Chang L; Zhu DY
Biochem Biophys Res Commun; 2020 Apr; 525(2):520-527. PubMed ID: 32113678
[TBL] [Abstract][Full Text] [Related]
9. Fgr contributes to hemorrhage-induced thalamic pain by activating NF-κB/ERK1/2 pathways.
Huang T; Fu G; Gao J; Zhang Y; Cai W; Wu S; Jia S; Xia S; Bachmann T; Bekker A; Tao YX
JCI Insight; 2020 Oct; 5(20):. PubMed ID: 33055425
[TBL] [Abstract][Full Text] [Related]
10. Small molecule inhibitors of PSD95-nNOS protein-protein interactions suppress formalin-evoked Fos protein expression and nociceptive behavior in rats.
Carey LM; Lee WH; Gutierrez T; Kulkarni PM; Thakur GA; Lai YY; Hohmann AG
Neuroscience; 2017 May; 349():303-317. PubMed ID: 28285942
[TBL] [Abstract][Full Text] [Related]
11. PCC-0105002, a novel small molecule inhibitor of PSD95-nNOS protein-protein interactions, attenuates neuropathic pain and corrects motor disorder associated with neuropathic pain model.
Sun Z; Meng P; Su C; Ji S; Gao Y; Wang H; Tian J; Li C
Toxicol Appl Pharmacol; 2021 Oct; 429():115698. PubMed ID: 34428447
[TBL] [Abstract][Full Text] [Related]
12. Regional Specific Modulation of Stress-Induced Neuronal Activation Associated with the PSD95/NOS Interaction Inhibitor ZL006 in the Wistar Kyoto Rat.
Sherwin E; Lennon A; Harkin A
Int J Neuropsychopharmacol; 2017 Oct; 20(10):833-843. PubMed ID: 28977524
[TBL] [Abstract][Full Text] [Related]
13. Targeting PSD95/nNOS by ZL006 alleviates social isolation-induced heightened attack behavior in mice.
Yang L; Cui J; Zeng L; Lu W
Psychopharmacology (Berl); 2022 Jan; 239(1):267-276. PubMed ID: 34661719
[TBL] [Abstract][Full Text] [Related]
14. Treatment of cerebral ischemia by disrupting ischemia-induced interaction of nNOS with PSD-95.
Zhou L; Li F; Xu HB; Luo CX; Wu HY; Zhu MM; Lu W; Ji X; Zhou QG; Zhu DY
Nat Med; 2010 Dec; 16(12):1439-43. PubMed ID: 21102461
[TBL] [Abstract][Full Text] [Related]
15. ZL006 protects spinal cord neurons against ischemia-induced oxidative stress through AMPK-PGC-1α-Sirt3 pathway.
Liu SG; Wang YM; Zhang YJ; He XJ; Ma T; Song W; Zhang YM
Neurochem Int; 2017 Sep; 108():230-237. PubMed ID: 28411102
[TBL] [Abstract][Full Text] [Related]
16. PSD-95-nNOS Coupling Regulates Contextual Fear Extinction in the Dorsal CA3.
Cai CY; Chen C; Zhou Y; Han Z; Qin C; Cao B; Tao Y; Bian XL; Lin YH; Chang L; Wu HY; Luo CX; Zhu DY
Sci Rep; 2018 Aug; 8(1):12775. PubMed ID: 30143658
[TBL] [Abstract][Full Text] [Related]
17. Biochemical investigations of the mechanism of action of small molecules ZL006 and IC87201 as potential inhibitors of the nNOS-PDZ/PSD-95-PDZ interactions.
Bach A; Pedersen SW; Dorr LA; Vallon G; Ripoche I; Ducki S; Lian LY
Sci Rep; 2015 Jul; 5():12157. PubMed ID: 26177569
[TBL] [Abstract][Full Text] [Related]
18. A Compound Mitigates Cancer Pain and Chemotherapy-Induced Neuropathic Pain by Dually Targeting nNOS-PSD-95 Interaction and GABA
Wei W; Liu W; Du S; Govindarajalu G; Irungu A; Bekker A; Tao YX
Neurotherapeutics; 2021 Oct; 18(4):2436-2448. PubMed ID: 34796458
[TBL] [Abstract][Full Text] [Related]
19. Disruption of nNOS-PSD95 protein-protein interaction inhibits acute thermal hyperalgesia and chronic mechanical allodynia in rodents.
Florio SK; Loh C; Huang SM; Iwamaye AE; Kitto KF; Fowler KW; Treiberg JA; Hayflick JS; Walker JM; Fairbanks CA; Lai Y
Br J Pharmacol; 2009 Sep; 158(2):494-506. PubMed ID: 19732061
[TBL] [Abstract][Full Text] [Related]
20. Intrathecal injection of the peptide myr-NR2B9c attenuates bone cancer pain via perturbing N-methyl-D-aspartate receptor-PSD-95 protein interactions in mice.
Liu Y; Cui X; Sun YE; Yang X; Ni K; Zhou Y; Ma Z; Gu X
Anesth Analg; 2014 Jun; 118(6):1345-54. PubMed ID: 24842180
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
